" /> Flotetuzumab - CISMeF





Preferred Label : Flotetuzumab;

NCIt synonyms : CD123 x CD3 Dual Affinity Re-Targeting Bi-Specific Antibody MGD006; CD123 x CD3 DART Bi-Specific Antibody MGD006;

NCIt definition : An anti-CD123/anti-CD3 bispecific humanized monoclonal antibody with potential immunostimulatory and antineoplastic activities. Flotetuzumab possesses two antigen-recognition and binding sites, one for the CD3 complex, a group of T-cell surface glycoproteins that complex with the T-cell receptor (TCR), and one for CD123, a tumor-associated antigen (TAA) overexpressed on the surface of certain tumor cells. Upon administration of flotetuzumab, this bispecific antibody simultaneously binds to both CD3-expressing T-cells and CD123-expressing cancer cells, thereby crosslinking CD123-expressing tumor cells and cytotoxic T-lymphocytes (CTLs). This may result in potent CTL-mediated cell lysis of CD123-expressing tumor cells. CD123, the interleukin-3 receptor alpha chain, is overexpressed in a variety of hematological malignancies; its expression is low or absent in normal hematopoietic progenitors and stem cells.;

UNII : 0AHT0IC02G;

CAS number : 1664355-28-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1664355-28-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : MGD006; RES234; S80880;

NCI Metathesaurus CUI : CL474112;

Details


You can consult :


Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.